Evidence map›Paper›PMID 30039889›Full record

ArticleCell proliferation2018

SNRPA enhances tumour cell growth in gastric cancer through modulating NGF expression.

Ning Dou, Dong Yang, Shijun Yu, Binghao Wu, Yong Gao, Yandong Li

Open access · bronzeAbstract read
In one paragraph

Article in Cell proliferation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 57 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. mAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Ning DouDepartment of Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
Dong YangDepartment of Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
Shijun YuDepartment of Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
Binghao WuHarvard Medical School, Massachusetts General Hospital, Cutaneous Biology Research Center, Charlestown, MA, USA.
Yong GaoDepartment of Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
Yandong LiDepartment of Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.ORCID http://orcid.org/0000-0001-8153-081X
Shanghai East Hospital · CNHarvard University · US

Funding

Key Disciplines Group Construction Project of Pudong Health Bureau of Shanghai PWZxq2017-13National Natural Science Foundation of China 81472576National Natural Science Foundation of China 81772567National Natural Science Foundation of China 81772568
6 · The paper itself

Abstract

objectivesSNRPA is a protein component of U1 small nuclear ribonucleoprotein (U1 snRNP) complex, which takes part in the splicing of pre-mRNAs. Its expression and function in tumour remain unknown. Herein, we elucidated the functional contribution of SNRPA to the progression of gastric cancer (GC). MATERIALS AND

methodsSNRPA expression was investigated in a GC tissue microarray by immunohistochemical staining. Cell proliferation was evaluated by CCK-8, colony formation and EdU incorporation assays. A mouse xenograft model was used to detect the tumourigenicity. Gene expression profiling was performed and then the potential target genes were verified by quantitative real-time PCR and western blot analyses. The functional relevance between SNRPA and its target gene was examined by cell growth assays.

resultsSNRPA expression was higher in tumour tissues than in matched normal gastric mucosa tissues, and it was positively correlated with the tumour size and progression. High SNRPA expression indicated poor prognosis of GC patients. Silencing SNRPA in GC cells markedly inhibited cell proliferation in vitro and tumour growth in a xenograft model, while overexpressing SNRPA exhibited opposite results. Moreover, we identified NGF (Nerve growth factor) as a downstream effector of SNRPA and further proved that NGF was crucial for SNRPA-mediated GC cell growth.

conclusionsThese findings suggested that SNRPA may contribute to GC progression via NGF and could be a prognostic biomarker for GC.

Indexed as

AdultAgedAged, 80 and overAnimalsCell Line, TumorCell ProliferationCell Transformation, NeoplasticDisease ProgressionFemaleGastric MucosaGene Expression Regulation, NeoplasticHumansMaleMiceMice, Inbred BALB CMice, NudeNerve Growth FactorNGF protein, humanRibonucleoprotein, U1 Small NuclearU1A protein

Identifiers

PMID30039889
PMCPMC6528855
OpenAlexW2884896818

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.